A first-of-its-kind initiative, Hilleman Laboratories is an equal joint-venture partnership formed between Merck & Co., a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to human and animal health. Headquartered in India, Hilleman Laboratories is a not-for-profit organization leveraging a cadre of talented scientists from around the globe.
Merck Sharp & Dohme Corp., is a global healthcare leader offering a diversified portfolio of prescription medicines, vaccines and animal & consumer health products.
Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in health by supporting the brightest minds.
Our expertise in medical research is targeted toward creating new vaccines in areas of unmet need as well as adapting existing vaccines for more effective delivery in low income nations. Numerous barriers hamper access to live-saving vaccines for millions of people living in the developing world. First, the lack of commercial return has limited private sector investment in new solutions for diseases that predominately affect low income countries. Secondly, many licensed vaccines available in the market today were developed and manufactured with industrialized world citizens in mind.
We aim to create a novel immunization platform by employing modern technologies focusing on :
- Reduced Footprint
Hilleman Laboratories will invest the majority of its resources in the research and clinical assessment of vaccines against strains of diseases prevalent in the developing world, (which bears 90% of the global burden of disease) Additionally, we will forge partnerships with governments, policy makers, multilateral and international organizations, public-private sector, research and technical institutes, NGOs, philanthropic organizations and other like-minded institutions. Hilleman Laboratories seeks to collaborate, exchange ideas and build a meaningful dialogue and advocacy platform for vaccine discovery to ultimately strengthen public health systems and immunization programs in developing countries over the long-term.
Vision, Mission & Values
"Developing vaccines for global health"
Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.
- Respect for All
We treat everyone with respect, irrespective of designation and hierarchy.
We work in a collaborative manner to achieve the best by rising above personal gains aspirations
- Innovation and Delivery
We apply innovation & cutting-edge technologies with a strong focus on execution and delivery.
- Proactive and Flexible
We are decisive and we take initiative. We maintain openness to change and to new directions.
We apply rigorous ethical principles in all interactions and dealing with various stakeholders.